Why the study?
Several registries and quality improvement initiatives have focused on assessing and improving secondary prevention of CVD in India.
This review highlights the landscape of CVD registries and quality improvement programs in India, emphasizing the need for data-driven policy to improve secondary prevention.
Answers are grounded in this paper and cite their sources.
Registry data reveal gaps in Indian CVD secondary prevention; leaves open need for targeted quality initiatives and policy evaluation.
Several registries and quality improvement initiatives have focused on assessing and improving secondary prevention of CVD in India. While the Treatment and Outcomes of Acute Coronary Syndromes in India (CREATE), Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF), and Trivandrum Heart Failure (THF) registries are limited to collecting data, the Tamil Nadu-ST-Segment Elevation Myocardial Infarction (TN-STEMI) program was aimed at examining and improving access to revascularization after an ST-elevation myocardial infarction (STEMI). The Acute Coronary Syndromes: Quality Improvement in Kerala (ACS-QUIK) study recruited hospitals from the Kerala ACS registry to assess a quality improvement kit for patients with ACS while the Practice Innovation and Clinical Excellence India Quality Improvement Program (PIQIP) provides valuable data on outpatient CVD quality of care. Collaborative efforts between health professionals are needed to assess further gaps in knowledge and policy makers to utilize new and existing data to drive policy-making.
No takes yet. Share an insight, caveat, or question.
Rehman et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: